Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;28:797-805

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touyz, R. M.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touyz, R. M.
Right arrow Articles by Schiffrin, E. L.

(Hypertension. 1996;28:797-805.)
© 1996 American Heart Association, Inc.


Articles

Intracellular Ca2+ Modulation by Angiotensin II and Endothelin-1 in Cardiomyocytes and Fibroblasts From Hypertrophied Hearts of Spontaneously Hypertensive Rats

Rhian M. Touyz; Jeannette Fareh; Gaetan Thibault; Ernesto L. Schiffrin

the Medical Research Council (MRC) Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal (Quebec, Canada).

The vasoactive peptides angiotensin II (Ang II) and endothelin-1 (ET-1) have been implicated in cardiac hypertrophy. This study investigates Ang II and ET-1 effects on intracellular free calcium concentration and the receptor subtype through which agonist-induced calcium responses are mediated in isolated cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats (SHR). We measured intracellular free calcium concentration by fura 2 methodology and determined receptor status by radioligand binding assays. Ang II (10-12 to 10-7 mol/L) had no effect on cardiomyocyte calcium levels in control Wistar-Kyoto rats but significantly increased (P<.01) intracellular free calcium concentration in a dose-dependent manner in cardiomyocytes from SHR. Ang II total and specific binding were increased (P<.05) in SHR cardiomyocytes. Calcium responses elicited by 10-7 to 10-5 mol/L Ang II were significantly reduced (P<.01) in SHR fibroblasts despite no significant change in Ang II receptor density. The angiotensin type 1 receptor blocker losartan (1 µmol/L) blocked Ang II–stimulated calcium transients, whereas the angiotensin type 2 receptor blocker PD 123319 had no effect. ET-1– and sarafotoxin S6c–induced calcium responses in cardiomyocytes and fibroblasts were not different between hypertensive and control groups. In conclusion, Ang II and ET-1 elicit distinct and differential responses in a cell-specific manner in cardiomyocytes and fibroblasts from hypertrophied hearts of SHR. Whereas Ang II–mediated effects, which are elicited via angiotensin type 1 receptors, are detectable in cardiomyocytes from SHR, responses to Ang II are blunted in fibroblasts from SHR, and ET-1–related actions are similar in cells from both rat groups. Stimulation of cardiomyocytes by Ang II in hypertrophied hearts associated with pressure overload in genetic hypertension suggests that Ang II could modulate the function of cardiomyocytes of SHR but not those of Wistar-Kyoto rats, whereas cardiac actions of ET-1 do not change with the development of hypertension.


Key Words: rats, inbred SHR • hypertrophy • angiotensin II • endothelin • intracellular • receptors, angiotensin




This article has been cited by other articles:


Home page
HypertensionHome page
E. Souzeau, B. Llamas, S. Belanger, S. Picard, and C. F. Deschepper
A Genetic Locus Accentuates the Effect of Volume Overload on Adverse Left Ventricular Remodeling in Male and Female Rats
Hypertension, January 1, 2006; 47(1): 128 - 133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Souzeau, S. Belanger, S. Picard, and C. F. Deschepper
Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H715 - H721.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. L. Hunton, L. Zou, Y. Pang, and R. B. Marchase
Adult rat cardiomyocytes exhibit capacitative calcium entry
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1124 - H1132.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. A Marganski, V. M De Biase, M. L Burgess, and M. Dembo
Demonstration of altered fibroblast contractile activity in hypertensive heart disease
Cardiovasc Res, December 1, 2003; 60(3): 547 - 556.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
I. Boutin-Ganache, S. Picard, and C. F. Deschepper
Distinct gene-sex interactions regulate adult rat cardiomyocyte width and length independently
Physiol Genomics, December 26, 2002; 12(1): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Hunton, P. A. Lucchesi, Y. Pang, X. Cheng, L. J. Dell'Italia, and R. B. Marchase
Capacitative Calcium Entry Contributes to Nuclear Factor of Activated T-cells Nuclear Translocation and Hypertrophy in Cardiomyocytes
J. Biol. Chem., April 12, 2002; 277(16): 14266 - 14273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Tardif, N. Julien, A. Pelletier, G. Thibault, A. K. Srivastava, J.-L. Chiasson, and L. Coderre
Chronic exposure to beta -hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1205 - E1212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. C. G. Daniels, R. S. Keller, and P. P. de Tombe
Losartan prevents contractile dysfunction in rat myocardium after left ventricular myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2150 - H2158.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Iwanaga, Y. Kihara, K. Inagaki, Y. Onozawa, T. Yoneda, K. Kataoka, and S. Sasayama
Differential Effects of Angiotensin II Versus Endothelin-1 Inhibitions in Hypertrophic Left Ventricular Myocardium During Transition to Heart Failure
Circulation, July 31, 2001; 104(5): 606 - 612.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Touyz, G. He, X.-H. Wu, J. B. Park, M. E. Mabrouk, and E. L. Schiffrin
Src Is an Important Mediator of Extracellular Signal-Regulated Kinase 1/2-Dependent Growth Signaling by Angiotensin II in Smooth Muscle Cells From Resistance Arteries of Hypertensive Patients
Hypertension, July 1, 2001; 38(1): 56 - 64.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Ceolotto, R. Valente, E. Baritono, S. Reato, E. Iori, A. Monari, R. Trevisan, and A. Semplicini
Effect of Insulin and Angiotensin II on Cell Calcium in Human Skin Fibroblasts
Hypertension, June 1, 2001; 37(6): 1486 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. M. Touyz and E. L. Schiffrin
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. G. Meszaros, A. M. Gonzalez, Y. Endo-Mochizuki, S. Villegas, F. Villarreal, and L. L. Brunton
Identification of G protein-coupled signaling pathways in cardiac fibroblasts: cross talk between Gq and Gs
Am J Physiol Cell Physiol, January 1, 2000; 278(1): C154 - C162.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Makino, M. Sugano, S. Ohtsuka, S. Sawada, and T. Hata
Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats
Cardiovasc Res, December 1, 1999; 44(3): 543 - 548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Ueno, T. Miyauchi, S. Sakai, T. Kobayashi, K. Goto, and I. Yamaguchi
Effects of physiological or pathological pressure load in vivo on myocardial expression of ET-1 and receptors
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1999; 277(5): R1321 - R1330.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Touyz and E. L. Schiffrin
Activation of the Na+-H+ Exchanger Modulates Angiotensin II–Stimulated Na+-Dependent Mg2+ Transport in Vascular Smooth Muscle Cells in Genetic Hypertension
Hypertension, September 1, 1999; 34(3): 442 - 449.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Fareh, R. M. Touyz, E. L. Schiffrin, and G. Thibault
Cardiac Type-1 Angiotensin II Receptor Status in Deoxycorticosterone Acetate–Salt Hypertension in Rats
Hypertension, November 1, 1997; 30(5): 1253 - 1259.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. F. Deschepper, S. Picard, G. Thibault, R. Touyz, and J.-L. Rouleau
Characterization of myocardium, isolated cardiomyocytes, and blood pressure in WKHA and WKY rats
Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H149 - H155.
[Abstract] [Full Text] [PDF]